About the solution
DiviDiaper is a unique, provisionally patented, diaper designed to prevent/reduce diaper dermatitis/rash (infants) and Incontinence-associated dermatitis (IAD) in adults; Urinary Tract Infections (UTI) and Catheter-Associated Urinary Tract Infections (CAUTIs); candida/yeast/fungal and other genital infections, and susceptibility to pressure sores. The divider's unique shape and elasticity contour comfortably to the perineal area to effectively separate urine from fecal matter, reducing/eliminating diaper rash and range of infections. The optional-use catheter hole and flap permit safe and effective separation of a catheter tube or super-pubic tube from the perineal/anus area to reduce many infections (including CAUTIs) and contamination of the catheter. We also have designed a diaper insert/pad with the divider that is in further development. This product will allow the wearer to have the benefits of DiviDiaper using other diaper brands. We created workable prototypes by hand, which have already been in used in post-op application, under the direction of a world-renown pediatric urologist and surgeon, Dr. Dix Poppas (Chief of Pediatric Urology, NY Presbyterian/Weill Cornell). DiviDiaper won INDA's 2018 RISE Innovation Award, competing against Freudenberg Group and Suominen. This innovative product, which was initially presented at Carlos Richer's Absorbent Hygiene New Trends workshop in November 2017 and featured on FOX 5 News this year, has been recognized by doctors and nurses as, not only being infection-reducing to the AI and infant populations, but also as potentially life-saving in cases where diaper- and catheter-associated infections resulted in fatal sepsis (not to mention having short- and long-term cost benefits). According to Dr. Dix Poppas, "it should be used by all [needing diapers because] it's just a better diaper [that] makes good sense." (July 2017).
This solution shall not include mention to the use of drugs, chemicals or biologicals (including food); invasive devices; offensive, commercial or inherently dangerous content. This solution was not medically validated. Proceed with caution! If you have any doubts, please consult with a health professional.
Student invents care wound technology inspired by a colleague
Son develops early skin cancer detector device after mom gets ill
Acral lentiginous melanoma
Acral lentiginous melanoma stage I
Acral lentiginous melanoma stage II
Acral lentiginous melanoma stage III
Acral lentiginous melanoma stage IV
Congenital melanocytic naevus
Juvenile melanoma benign
Malignant melanoma in situ
Malignant melanoma stage I
Malignant melanoma stage II
Malignant melanoma stage III